Cash flow Molina Healthcare, Inc.

Equities

MOH

US60855R1005

Managed Healthcare

Market Closed - Nyse Other stock markets 21:00:02 18/07/2025 BST			5-day change	1st Jan Change
182.98 ^USD	-10.41%		-17.41%	-37.13%

07-17	Elevance cuts forecast as US health insurers battle higher costs	RE
07-17	Elevance Health 2Q EPS Down, 2025 Profit View Cut	DJ

4.4LSG3--QVMqMTRZAk1753-QGj_q3ME3L6vW_zf6A3ms.0_jgqL_aOprNKEd3yzDNi5Zv2q3OWgWk0pfS_pP27FuF38yYoeADiOs1ZQ

Published financial data: MOLINA HEALTHCARE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Premiums and Annuity Revenues	18.3B	26.86B	30.88B	32.53B	38.63B
Total Interest And Dividend Income	76M	52M	143M	404M	453M
Gain (Loss) on Sale of Investments, Total (Rev)	-	-	-	-10M	-1M
Other Revenues, Total	-	77M	75M	80M	85M
Total Revenues	18.38B	26.98B	31.1B	33B	39.16B
Policy Benefits	15.82B	23.7B	27.18B	28.67B	34.43B
Depreciation & Amortization - (IS) - (Collected)	88M	131M	176M	171M	186M
Selling General & Admin Expenses, Total	1.41B	1.96B	2.21B	2.34B	2.63B
Salaries And Other Employee Benefits	57M	72M	103M	115M	116M
Other Operating Expenses	31M	37M	54M	87M	100M
Total Operating Expenses	17.4B	25.91B	29.71B	31.38B	37.46B
Operating Income	972M	1.08B	1.39B	1.62B	1.71B
Interest Expense, Total	-102M	-120M	-110M	-109M	-118M
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	870M	958M	1.28B	1.51B	1.59B
Restructuring Charges	-	-	-	-	-
Total Merger & Related Restructuring Charges	-16M	-34M	-2M	-4M	-1M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-
Asset Writedown	-	-	-208M	-	-
Legal Settlements	128M	-	-	-	-
Other Unusual Items	-21M	-49M	-4M	-41M	-
EBT, Incl. Unusual Items	961M	875M	1.06B	1.46B	1.59B
Income Tax Expense	288M	216M	271M	373M	410M
Earnings From Continuing Operations	673M	659M	792M	1.09B	1.18B
Net Income to Company	673M	659M	792M	1.09B	1.18B
Net Income - (IS)	673M	659M	792M	1.09B	1.18B
Net Income to Common Incl Extra Items	673M	659M	792M	1.09B	1.18B
Net Income to Common Excl. Extra Items	673M	659M	792M	1.09B	1.18B
Per Share Items
Net EPS - Basic	11.41	11.4	13.7	18.91	20.54
Basic EPS - Continuing Operations	11.41	11.4	13.7	18.91	20.54
Basic Weighted Average Shares Outstanding	59M	57.8M	57.8M	57.7M	57.4M
Net EPS - Diluted	11.23	11.25	13.55	18.77	20.42
Diluted EPS - Continuing Operations	11.23	11.25	13.55	18.77	20.42
Diluted Weighted Average Shares Outstanding	59.9M	58.6M	58.5M	58.1M	57.7M
Normalized Basic EPS	9.22	10.36	13.81	16.35	17.31
Normalized Diluted EPS	9.08	10.22	13.64	16.23	17.22
Supplemental Items
EBITDA	1.02B	1.17B	1.51B	1.73B	1.82B
EBITA	987M	1.13B	1.46B	1.7B	1.79B
EBIT	972M	1.08B	1.39B	1.62B	1.71B
EBITDAR	1.05B	1.2B	1.54B	1.75B	1.84B
Total Revenues (As Reported)	19.42B	27.77B	31.97B	34.07B	40.65B
Effective Tax Rate - (Ratio)	29.97	24.69	25.49	25.48	25.8
Current Domestic Taxes	307M	240M	337M	404M	357M
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	307M	240M	337M	404M	357M
Deferred Domestic Taxes	-20M	-24M	-66M	-31M	53M
Deferred Foreign Taxes	1M	-	-	-	-
Total Deferred Taxes	-19M	-24M	-66M	-31M	53M
Normalized Net Income	544M	599M	798M	943M	994M
Interest on Long-Term Debt	15M	15M	15M	15M	15M
Supplemental Operating Expense Items
General and Administrative Expenses	1.41B	1.96B	2.21B	2.34B	2.63B
Net Rental Expense, Total	28M	33M	31M	15M	14M
Imputed Operating Lease Interest Expense	11.4M	12.72M	10.76M	5.19M	4.61M
Imputed Operating Lease Depreciation	16.6M	20.28M	20.24M	9.81M	9.39M
Stock-Based Comp., G&A Exp. (Total)	57M	72M	103M	115M	116M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	57M	72M	103M	115M	116M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Total Other Investments	1.88B	3.2B	3.5B	4.26B	4.32B
Total investments	1.88B	3.2B	3.5B	4.26B	4.32B
Cash And Equivalents	4.15B	4.44B	4.01B	4.85B	4.66B
Reinsurance Recoverable - (IS)	-	-	-	-	-
Other Receivables - (Insurance Template)	1.68B	2.19B	2.34B	3.16B	3.36B
Gross Property Plant And Equipment	564M	609M	382M	355M	341M
Accumulated Depreciation	-192M	-205M	-213M	-192M	-194M
Net Property Plant And Equipment	372M	404M	169M	163M	147M
Goodwill	692M	982M	1.12B	1.24B	1.67B
Other Intangibles, Total	339M	390M	408M	358M	443M
Other Current Assets, Total	165M	236M	242M	278M	431M
Deferred Tax Assets Long-Term (Collected)	69M	106M	220M	227M	207M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	184M	263M	318M	361M	389M
Total Assets	9.53B	12.21B	12.31B	14.89B	15.63B
Liabilities
Accounts Payable, Total	584M	792M	826M	1.21B	1.28B
Accrued Expenses, Total	1.25B	2.47B	2.08B	2.29B	1.88B
Unpaid Claims	2.7B	3.36B	3.53B	4.2B	4.64B
Unearned Premiums	375M	370M	359M	418M	51M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	33M	50M	63M	41M	38M
Long-Term Debt	2.13B	2.17B	2.18B	2.18B	2.92B
Long-Term Leases	280M	318M	292M	290M	263M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	24M	-	-	-	-
Deferred Tax Liability Non-Current	-	-	-	-	-
Other Non Current Liabilities	64M	41M	27M	39M	52M
Total Liabilities	7.44B	9.58B	9.35B	10.68B	11.13B
Additional Paid In Capital	199M	236M	328M	410M	462M
Retained Earnings	1.86B	2.4B	2.8B	3.89B	4.09B
Comprehensive Income and Other	37M	-5M	-160M	-82M	-57M
Total Common Equity	2.1B	2.63B	2.96B	4.22B	4.5B
Total Equity	2.1B	2.63B	2.96B	4.22B	4.5B
Total Liabilities And Equity	9.53B	12.21B	12.31B	14.89B	15.63B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	58M	58.4M	57.9M	58.4M	55.5M
ECS Total Common Shares Outstanding	59M	58M	58M	58M	56M
Book Value / Share	35.53	45.34	51.1	72.67	80.29
Tangible Book Value	1.06B	1.26B	1.44B	2.62B	2.38B
Tangible Book Value Per Share	18.05	21.69	24.84	45.1	42.54
Total Debt	2.44B	2.54B	2.53B	2.51B	3.22B
Net Debt	-1.71B	-1.9B	-1.48B	-2.34B	-1.44B
Debt Equivalent Oper. Leases	224M	264M	248M	120M	112M
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	4M	1M	5M	5M	1M
Buildings, Total	49M	37M	41M	41M	35M
Machinery, Total	221M	237M	221M	199M	205M
Full Time Employees	10.5K	14K	15K	18K	18K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	673M	659M	792M	1.09B	1.18B
Depreciation, Depletion & Amortization	35M	41M	45M	28M	35M
Amortization of Goodwill and Intangible Assets - (CF)	15M	49M	77M	85M	82M
Total Depreciation, Depletion & Amortization	50M	90M	122M	113M	117M
Amortization of Deferred Charges, Total	38M	41M	54M	58M	69M
(Gain) Loss On Sale of Asset - (CF)	-	-	-	-	-
Total Asset Writedown	-	-	208M	-	-
Restructuring Activities	-	-	-	-	-
Stock-Based Compensation (CF)	57M	72M	103M	115M	116M
Change in Accounts Receivable	-100M	-415M	-95M	-778M	-78M
Change in Accounts Payable	78M	138M	55M	328M	115M
Change in Unearned Revenues	126M	-5M	-11M	59M	-367M
Change In Income Taxes	-14M	7M	2M	-2M	-18M
Change in insurance Reserves / Liabilities	544M	471M	153M	580M	-40M
Change in Other Net Operating Assets (Collected)	430M	1.03B	-552M	127M	-510M
Other Operating Activities	8M	34M	-58M	-29M	61M
Cash from Operations	1.89B	2.12B	773M	1.66B	644M
Capital Expenditure	-74M	-77M	-91M	-84M	-100M
Cash Acquisitions	-755M	-129M	-134M	-3M	-344M
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	427M	-1.38B	-515M	-661M	-21M
Other Investing Activities, Total	2M	-63M	-50M	4M	1M
Cash from Investing	-400M	-1.65B	-790M	-744M	-464M
Long-Term Debt Issued, Total	1.81B	740M	-	-	1.04B
Total Debt Issued	1.81B	740M	-	-	1.04B
Long-Term Debt Repaid, Total	-950M	-723M	-	-	-300M
Total Debt Repaid	-950M	-723M	-	-	-300M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-606M	-181M	-454M	-60M	-1.06B
Other Financing Activities, Total	-28M	-19M	13M	2M	-30M
Cash from Financing	225M	-183M	-441M	-58M	-347M
Net Change in Cash	1.72B	283M	-458M	860M	-167M
Supplemental Items
Cash Interest Paid	112M	127M	108M	108M	121M
Cash Income Tax Paid (Refund)	321M	235M	340M	405M	379M
Net Debt Issued / Repaid	859M	17M	-	-	740M
Levered Free Cash Flow	2.12B	886M	329M	864M	510M
Unlevered Free Cash Flow	2.19B	961M	398M	932M	584M
Change In Net Working Capital	-1.51B	-161M	657M	281M	686M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	7.45	6.2	7.07	7.43	6.99
Return on Total Capital	15.07	13.88	16.25	16.55	14.78
Return On Equity %	33.19	27.89	28.32	30.39	27.07
Return on Common Equity	33.19	27.89	28.32	30.39	27.07
Margin Analysis
Gross Profit Margin %	13.9	12.16	12.62	13.13	12.09
SG&A Margin	7.97	7.54	7.42	7.45	7
EBITDA Margin %	5.56	4.33	4.85	5.24	4.66
EBITA Margin %	5.37	4.18	4.71	5.16	4.57
EBIT Margin %	5.29	3.99	4.46	4.9	4.36
Income From Continuing Operations Margin %	3.66	2.44	2.55	3.31	3.01
Net Income Margin %	3.66	2.44	2.55	3.31	3.01
Net Avail. For Common Margin %	3.66	2.44	2.55	3.31	3.01
Normalized Net Income Margin	2.96	2.22	2.57	2.86	2.54
Levered Free Cash Flow Margin	11.55	3.28	1.06	2.62	1.3
Unlevered Free Cash Flow Margin	11.89	3.56	1.28	2.82	1.49
Asset Turnover
Asset Turnover	2.25	2.48	2.54	2.43	2.57
Fixed Assets Turnover	48.87	69.55	108.55	198.81	252.67
Receivables Turnover (Average Receivables)	-	-	-	-	-
Short Term Liquidity
Current Ratio	1.59	1.43	1.47	1.54	1.62
Quick Ratio	1.55	1.39	1.43	1.49	1.56
Operating Cash Flow to Current Liabilities	0.38	0.3	0.11	0.2	0.08
Days Sales Outstanding (Average Receivables)	-	-	-	-	-
Average Days Payable Outstanding	64.27	57.43	57.14	62.19	60.28
Long Term Solvency
Total Debt/Equity	116.41	96.62	85.39	59.57	71.71
Total Debt / Total Capital	53.79	49.14	46.06	37.33	41.76
LT Debt/Equity	114.84	94.71	83.27	58.6	70.86
Long-Term Debt / Total Capital	53.06	48.17	44.91	36.72	41.27
Total Liabilities / Total Assets	78.01	78.46	75.93	71.7	71.23
EBIT / Interest Expense	9.53	8.98	12.61	14.84	14.47
EBITDA / Interest Expense	10.29	10.01	14	16.02	15.58
(EBITDA - Capex) / Interest Expense	9.57	9.37	13.17	15.25	14.74
Total Debt / EBITDA	2.32	2.12	1.64	1.44	1.75
Net Debt / EBITDA	-1.63	-1.58	-0.96	-1.34	-0.78
Total Debt / (EBITDA - Capex)	2.5	2.26	1.75	1.51	1.85
Net Debt / (EBITDA - Capex)	-1.76	-1.69	-1.02	-1.41	-0.83
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.45	46.85	15.26	6.12	18.67
Gross Profit, 1 Yr. Growth %	4.93	28.38	19.7	10.39	9.28
EBITDA, 1 Yr. Growth %	-7.09	16.1	33.07	14.86	5.67
EBITA, 1 Yr. Growth %	-7.06	16.07	33.94	16.48	5.36
EBIT, 1 Yr. Growth %	-6.9	12.76	32.85	16.82	5.82
Earnings From Cont. Operations, 1 Yr. Growth %	-8.68	-2.08	20.18	37.75	8.07
Net Income, 1 Yr. Growth %	-8.68	-2.08	20.18	37.75	8.07
Normalized Net Income, 1 Yr. Growth %	-9.09	12.18	38.2	18.35	5.65
Diluted EPS Before Extra, 1 Yr. Growth %	-2.09	0.18	20.44	38.52	8.79
Net Property, Plant and Equip., 1 Yr. Growth %	-2.11	8.6	-58.17	-3.55	-9.82
Accounts Receivable, 1 Yr. Growth %	-	-	-	-	-
Total Assets, 1 Yr. Growth %	40.44	28.08	0.86	20.94	4.96
Common Equity, 1 Yr. Growth %	6.94	25.48	12.7	42.21	6.67
Tangible Book Value, 1 Yr. Growth %	-38.01	18.12	14.55	81.54	-8.94
Cash From Operations, 1 Yr. Growth %	342.62	11.64	-63.52	115.01	-61.25
Capital Expenditures, 1 Yr. Growth %	29.82	4.05	18.18	-7.69	19.05
Levered Free Cash Flow, 1 Yr. Growth %	67.8K	-58.06	-61.93	163.55	-40.84
Unlevered Free Cash Flow, 1 Yr. Growth %	3.7K	-55.84	-57.65	135.05	-37.24
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.63	28.51	30.1	10.59	12.22
Gross Profit, 2 Yr. CAGR %	-7.82	16.06	23.96	14.95	9.83
EBITDA, 2 Yr. CAGR %	-7.25	3.04	22.84	24.88	10.19
EBITA, 2 Yr. CAGR %	-7.44	3.01	23.17	26.22	10.8
EBIT, 2 Yr. CAGR %	-7.3	1.62	20.83	25.95	11.21
Earnings From Cont. Operations, 2 Yr. CAGR %	-2.43	-5.44	8.48	28.67	22.01
Net Income, 2 Yr. CAGR %	-2.43	-5.44	8.48	28.67	22.01
Normalized Net Income, 2 Yr. CAGR %	-7.69	0.05	22.72	31.32	11.85
Diluted EPS Before Extra, 2 Yr. CAGR %	2.88	-0.96	9.84	29.17	22.76
Net Property, Plant and Equip., 2 Yr. CAGR %	40.67	3.11	-32.6	-36.48	-6.74
Accounts Receivable, 2 Yr. CAGR %	-	-	-	-	-
Total Assets, 2 Yr. CAGR %	15.43	34.12	13.66	10.44	12.66
Common Equity, 2 Yr. CAGR %	12.81	15.84	18.92	26.6	23.16
Tangible Book Value, 2 Yr. CAGR %	-12.91	-14.43	16.32	44.2	28.57
Cash From Operations, 2 Yr. CAGR %	145.34	120.96	-36.18	-11.44	-8.72
Capital Expenditures, 2 Yr. CAGR %	57.06	16.23	10.89	4.45	4.83
Levered Free Cash Flow, 2 Yr. CAGR %	96.59	1.58K	-60.49	0.86	25.17
Unlevered Free Cash Flow, 2 Yr. CAGR %	87.62	308.76	-57.2	0.42	21.68
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.87	14.15	23.93	21.56	13.22
Gross Profit, 3 Yr. CAGR %	2.51	2.94	17.26	19.26	13.03
EBITDA, 3 Yr. CAGR %	66.35	-0.56	11.11	20.07	18.03
EBITA, 3 Yr. CAGR %	76.34	-0.73	11.29	20.85	18.75
EBIT, 3 Yr. CAGR %	86.85	-1.59	9.93	19.42	18.75
Earnings From Cont. Operations, 3 Yr. CAGR %	9.54	-2.32	2.43	17.47	21.4
Net Income, 3 Yr. CAGR %	9.54	-2.32	2.43	17.47	21.4
Normalized Net Income, 3 Yr. CAGR %	101.71	-2.1	10.09	21.18	22.03
Diluted EPS Before Extra, 3 Yr. CAGR %	7.35	1.97	5.71	18.68	21.98
Net Property, Plant and Equip., 3 Yr. CAGR %	16.88	29.04	-23.67	-24.05	-28.61
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-	-
Total Assets, 3 Yr. CAGR %	4.01	19.5	21.97	16.04	8.58
Common Equity, 3 Yr. CAGR %	16.17	16.88	14.78	26.22	19.57
Tangible Book Value, 3 Yr. CAGR %	3.06	-3.59	-5.69	34.93	23.71
Cash From Operations, 3 Yr. CAGR %	32.96	88.97	21.22	-4.33	-32.77
Capital Expenditures, 3 Yr. CAGR %	-4.89	36.92	16.88	4.32	9.1
Levered Free Cash Flow, 3 Yr. CAGR %	136.39	17.29	372.25	-25.71	-15.65
Unlevered Free Cash Flow, 3 Yr. CAGR %	163.93	15.66	90.56	-24.56	-14.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.3	9.65	9.85	12.71	19.1
Gross Profit, 5 Yr. CAGR %	7.95	7.85	10.6	7.58	14.23
EBITDA, 5 Yr. CAGR %	17.57	24.98	46.71	7.82	10.66
EBITA, 5 Yr. CAGR %	19.56	27.23	52.07	8.13	11.01
EBIT, 5 Yr. CAGR %	20.22	28.64	56.23	7.42	10.35
Earnings From Cont. Operations, 5 Yr. CAGR %	36.31	66.18	9.12	9.06	9.85
Net Income, 5 Yr. CAGR %	36.31	66.18	9.12	9.06	9.85
Normalized Net Income, 5 Yr. CAGR %	21.99	36.12	64.5	8.13	10.69
Diluted EPS Before Extra, 5 Yr. CAGR %	34.2	65	8.34	12.09	12.23
Net Property, Plant and Equip., 5 Yr. CAGR %	8.1	8.39	-6.22	-2.81	-17.3
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	-
Total Assets, 5 Yr. CAGR %	7.71	10.39	7.77	15.79	18.16
Common Equity, 5 Yr. CAGR %	6.13	9.79	17.26	20.68	18.06
Tangible Book Value, 5 Yr. CAGR %	6.56	12.28	8.17	13.25	6.75
Cash From Operations, 5 Yr. CAGR %	10.93	25.78	-0.78	39.55	8.21
Capital Expenditures, 5 Yr. CAGR %	-10.93	-15.24	1.14	22.87	11.9
Levered Free Cash Flow, 5 Yr. CAGR %	74.11	4.11	15.43	9.5	177.01
Unlevered Free Cash Flow, 5 Yr. CAGR %	72.31	4.9	27.33	8.47	58.96